Showing 281-290 of 747 results for "".
Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manPearls for Management of Steroid-Responsive Dermatoses
https://practicaldermatology.com/topics/general-topics/pearls-for-management-of-steroid-responsive-dermatoses/21958/From side effects to therapeutic combinations to consider, here is an update on the latest approaches to management of steroid-responsive dermatoses.Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.Psoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/psoriasis-biologics-and-cardiovascular-disease-the-heart-of-the-matter/23215/A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.2020 In Review
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2020-in-review/23402/Top trends and developments from the yearNewly Approved Therapies for the Treatment of Plaque Psoriasis in Adults
https://practicaldermatology.com/topics/psoriasis/newly-approved-therapies-for-the-treatment-of-plaque-psoriasis-in-adults/23213/Here’s a closer a look at recently approved agents.Topical Steroid Withdrawal in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-steroid-withdrawal-in-atopic-dermatitis/23079/Exploring the important role and proper use of topical corticosteroids in the management of eczema.Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.